Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells.
Open Access
- 1 July 1990
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 172 (1) , 47-52
- https://doi.org/10.1084/jem.172.1.47
Abstract
We analyzed the recently defined ability of CD3-CD16+ cells to specifically recognize and lyse normal allogeneic target cells (PHA-induced blasts). The susceptibility to lysis by a given alloreactive natural killer (NK) clone ("1 anti-A") was expressed by PHA blasts derived from 9 of 38 random donors analyzed. In all instances, the specific lysis of "susceptible" target cells was greater than 35% while that of "nonsusceptible" targets was less than 6% at an E/T cell ratio of 5:1. In addition to 1 anti-A, A anti-1 specific CD3-CD16+ clones could also be isolated from the reverse MLC combination. The relationship existing between lysis of normal allogeneic cells or tumor cells by the same CD3-CD16+ effector cell has been investigated: 1 anti-A specific CD3-CD16+ clones lysed PHA blasts of three of six cancer patients, while they lysed fresh tumor cells (ovarian carcinoma) from all six patients. The type of inheritance of the character "susceptibility to lysis" was analyzed in representative families. This analysis revealed that the character is inherited in an autosomic recessive fashion, and it is therefore different from MHC. We further investigated the type of segregation of the opposite character "resistance to lysis" (which is inherited in a dominant mode). The finding that this character segregated in all donors expressing given MHC haplotypes indicated that the gene regulating the expression of the NK-defined alloantigen is present on chromosome 6.This publication has 12 references indexed in Scilit:
- Identification of a subset of murine natural killer cells that mediates rejection of Hh-1d but not Hh-1b bone marrow grafts.The Journal of Experimental Medicine, 1989
- Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes.Proceedings of the National Academy of Sciences, 1989
- Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture.The Journal of Experimental Medicine, 1988
- Bone marrow cell transplants involving intra-H-2 recombinant inbred mouse strains. Evidence that hemopoietic histocompatibility-1 (Hh-1) genes are distinct from H-2D or H-2L.The Journal of Immunology, 1988
- Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor.The Journal of Experimental Medicine, 1988
- A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s).The Journal of Experimental Medicine, 1988
- CD3-negative lymphokine-activated cytotoxic cells express the CD3 epsilon gene.The Journal of Immunology, 1988
- Biology and Genetics of Hybrid ResistancePublished by Elsevier ,1987
- Modulation of surface T11 molecules induced by monoclonal antibodies: analysis of the functional relationship between antigen‐dependent and antigen‐independent pathways of human T cell activationEuropean Journal of Immunology, 1986
- PECULIAR IMMUNOBIOLOGY OF BONE MARROW ALLOGRAFTSThe Journal of Experimental Medicine, 1971